US1252691001 - Common Stock
2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue YoY % growth | 6.538B 58.54% | 11.186B 71.09% | 6.631B -40.72% | 6.238B -5.93% | ||||||||
EBITDA YoY % growth | 3.072B 102.64% | 6.421B 109.02% | 3.121B -51.39% | 2.505B -19.74% | ||||||||
EBIT YoY % growth | 2.184B 250.00% | 5.571B 155.08% | 2.252B -59.58% | 1.795B -20.29% | N/A | N/A | N/A | N/A | ||||
Operating Margin | 33.40% | 49.80% | 33.96% | 28.78% | N/A | N/A | N/A | N/A | ||||
EPS YoY % growth | 4.29 184.11% | 16.95 295.10% | 8.33 -50.86% | 6.38 -23.40% |
All data in USD
Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
---|---|---|---|---|---|---|---|---|---|---|---|
EPS Q2Q % growth | 2.28 -16.00% | ||||||||||
Revenue Q2Q % growth | 1.72B -3.10% | ||||||||||
EBITDA Q2Q % growth | 773.68M | ||||||||||
EBIT Q2Q % growth | 666.56M -8.57% |
All data in USD
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q1 2024 Q2Q % growth | 1.03 -64.48% | 1.57 | -0.54 | -34.39% |
Q4 2023 Q2Q % growth | 1.58 -63.08% | 1.62 | -0.04 | -2.45% |
Q3 2023 Q2Q % growth | 1.14 -49.78% | 1.06 | 0.08 | 7.78% |
Q2 2023 Q2Q % growth | 2.71 -56.22% | 2.32 | 0.39 | 16.76% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q1 2024 Q2Q % growth | 1.47B -26.94% | 1.503B | -33M | -2.20% |
Q4 2023 Q2Q % growth | 1.571B -39.76% | 1.541B | 30M | 1.95% |
Q3 2023 Q2Q % growth | 1.273B -45.15% | 1.335B | -62M | -4.64% |
Q2 2023 Q2Q % growth | 1.775B -47.62% | 1.855B | -80M | -4.31% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | -2.82% | -20.66% | -1.33% | -8.18% |
Revenue | -2.08% | -12.67% | 0% | -4.76% |